butabarbital decreases outcomes of sufentanil SL by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Monitor Carefully. Coadministration of CYP3A4 inducers may lessen sufentanil degrees and efficacy, maybe precipitating withdrawal syndrome in patients who've created Bodily dependence to sufentanil. Discontinuation of concomitan